• EdU Flow Cytometry Assay Kits (Cy3): S-Phase Analysis

  2026-08-08

  EdU Flow Cytometry Assay Kits (Cy3) measure active DNA synthesis by coupling EdU incorporation to Cy3 fluorescence through click chemistry. The workflow supports quantitative S-phase analysis without the harsh DNA denaturation used in many BrdU protocols, making it suitable for multiplexed proliferation, genotoxicity, and pharmacodynamic studies.

• AI-10-49 in CBFβ-SMMHC AML Research

  2026-08-07

  AI-10-49 enables a mechanism-led workflow for inv(16) leukemia research, connecting CBFβ-SMMHC–RUNX1 dissociation with chromatin, survival, and transcriptional readouts. This guide shows how to optimize cell-based assays, chromatin immunoprecipitation, and in vivo leukemia mouse model studies while avoiding common solubility and interpretation errors.

• CPI-613: Redefining Mitochondrial Apoptosis in Cancer Resear

  2026-08-07

  Explore how CPI-613, a first-in-class mitochondrial metabolism inhibitor, uniquely targets the pyruvate dehydrogenase complex in tumor cells. This article connects advanced mechanistic insights with practical assay design for apoptosis and drug resistance research.

• Guanabenz Acetate: Precision Modulation in Translational Neu

  2026-08-06

  Explore how Guanabenz Acetate, a selective α2-adrenergic receptor agonist, is redefining experimental strategies in neuroscience and immunology. This article bridges mechanistic insight with actionable guidance, spotlighting emerging evidence on GPCR signaling, stress granule dynamics, and viral immune evasion. Key protocol considerations and strategic outlooks position APExBIO’s Guanabenz Acetate as a transformative tool for translational research.

• AI-10-49: Precision Targeting of CBFβ-SMMHC in Leukemia Rese

  2026-08-06

  Explore how AI-10-49, a potent CBFβ-SMMHC inhibitor, unlocks new avenues in acute myeloid leukemia research by restoring RUNX1 function and modulating the N-MYC/eIF4G1 axis. This article delivers unique insights into assay design, translational impact, and protocol optimization.

• Bay 11-7821: Translating Mechanistic Insight to Next-Gen Inf

  2026-08-05

  Explore how Bay 11-7821 (BAY 11-7082) redefines translational strategies in inflammatory signaling and apoptosis research. This thought-leadership article bridges recent discoveries in lactate-driven HMGB1 release with actionable guidance for leveraging Bay 11-7821 in complex models of sepsis and cancer. Integrating mechanistic evidence, competitive context, and protocol recommendations, we highlight how APExBIO’s Bay 11-7821 positions researchers at the forefront of immune modulation and disease intervention.

• CKI 7 Dihydrochloride: Applied Protocols for Casein Kinase 1

  2026-08-05

  CKI 7 dihydrochloride empowers researchers to dissect Casein kinase 1 signaling in cancer and circadian regulation with unmatched precision. Explore step-by-step workflows, optimization strategies, and troubleshooting insights, all grounded in recent breakthroughs and best-in-class product performance.

• Silybin A in Silymarin: Precision Workflows for Liver Resear

  2026-08-04

  Silybin A, the principal flavonolignan of Silymarin, drives reproducible, high-fidelity workflows across liver, metabolic, and inflammation research. This guide delivers actionable protocols, advanced troubleshooting, and a direct translation of innovative findings to elevate hepatoprotective assay performance.

• Carvacrol in Cell Cycle and Redox Research: Protocols & Insi

  2026-08-04

  Carvacrol (5-isopropyl-2-methylphenol) unlocks advanced workflows in cell cycle arrest, apoptosis, and redox signaling research. Learn how to optimize experimental design, troubleshoot solubility and stability challenges, and leverage the latest TRP channel findings for translational impact.

• Thiothixene Stimulates Macrophage Efferocytosis via Arginase

  2026-08-03

  The reference study identifies thiothixene, a typical antipsychotic agent, as a potent stimulator of macrophage efferocytosis through induction of Arginase 1 and the retinol-binding protein receptor Stra6L. These findings bridge neuropharmacology and immunology, suggesting new therapeutic angles for diseases marked by defective apoptotic cell clearance.

• Mdivi-1: Selective DRP1 Inhibitor for Mitochondrial Dynamics

  2026-08-03

  Mdivi-1 revolutionizes mitochondrial dynamics research by enabling precise, reproducible inhibition of DRP1-mediated fission in both cellular and animal models. Its unique selectivity and robust cell permeability empower advanced apoptosis assays, neuroprotection studies, and mechanistic explorations of mitochondrial signaling.

• ECE-1c Stabilization Drives Cisplatin Resistance in Lung Can

  2026-08-02

  Almarza et al. (2024) identify a CK2-mediated stabilization of ECE-1c as a mechanism that enhances stemness, invasiveness, and cisplatin resistance in non–small cell lung cancer (NSCLC) cells. These findings implicate phospho-ECE-1c as a biomarker and suggest CK2 inhibition as a potential therapeutic approach.

• Decitabine (5-Aza-2'-deoxycytidine): Applied Cancer Epigenet

  2026-08-01

  Decitabine (5-Aza-2'-deoxycytidine) is a gold-standard DNA methyltransferase inhibitor uniquely suited for translational cancer epigenetic studies. This guide delivers actionable workflows and troubleshooting to optimize its use in tumor suppressor gene reactivation and immunomodulatory protocols across both hematopoietic and solid tumor models.

• PLK1-Dependent NEK7 Phosphorylation Regulates NLRP3 Inflamma

  2026-07-31

  This study identifies GSK461364 as a selective inhibitor of the NLRP3 inflammasome, acting through the disruption of PLK1-mediated phosphorylation of NEK7. The findings reveal a new regulatory axis for inflammasome assembly and highlight targeted phosphorylation analysis as a key tool for dissecting signal transduction in inflammatory disease.

• Dorsomorphin 2HCl: Precision Inhibition of AMPK and BMP Path

  2026-07-31

  Explore how Dorsomorphin 2HCl, a potent AMPK inhibitor, uniquely enables precise, mechanism-driven research in metabolic and bone signaling. Discover advanced protocols and insights that set this cornerstone apart from existing content.

442 records 8/30 page Previous Next First page 上5页 678910 下5页 Last page